Investment Analyst - Prudential Private Capital (PPC) FT 2021

Does anyone know a decent amount about this group? I applied for this last week and got picked for a first round interview (I have a background in corp fin at a large AM) and am curious as to if anyone knows what the culture is like, general exit opps, thoughts on the program itself and any tips for preparing for the interview. First portion is strictly behavioral questions and the second portion is specific to the business unit. The job description is as follows:

**As an Investment Analyst, you would work on a small deal team responsible for underwriting, portfolio monitoring and marketing, while getting the chance to develop your analytical skills and learn to think like a buy-and-hold investor in a three-year analyst program. You will learn about investing private placements of senior debt and junior capital within a variety of industries from large, multi-national companies to smaller, privately-held companies. Many of our analysts move on to attend top business schools and have received a variety of opportunities within the industry at the close of the three-year Investment Analyst program.

Job Responsibilities: Write internal credit memos Industry and company research Comparable analysis Financial modeling and credit analysis Transaction and due diligence support Portfolio and credit monitoring Communication with portfolio companies Prepare marketing materials**

139 Comments
 

All I could find for SA was the Dallas energy group. Is that the only slot open?

The important thing is never to let oneself be guided by the opinion of one's contemporaries; to continue steadfastly on one's way without letting oneself be either defeated by failure or diverted by applause.
 

I applied for PPC SA and selected nyc and sf as preferred locations. not sure about Dallas or the groups sorry

 

"Prudential Private Capital (formerly known as Prudential Capital Group) is the private capital arm of PGIM, the $1.2 trillion global investment management business of Prudential Financial, Inc. (NYSE:PRU). Expertise, analysis, and experience drive everything we do."

 

Hi, I cannot PM anymore, but I am applying for the same role in this cycle as well. Would you mind PMing me, so we can talk about this? Thanks. 

 

Interviewed many years ago for the Prudential Capital Group Investment Analyst role at their NYC location.

First Round was mostly behavioral. In fact, I cannot recall if technicals were included in this round.

Superday was a written test and interview with different members of the team with a mix of technicals and behaviorals. Didn't land the role but the competition was stiff (one of the people interviewing was a guy from IB who was looking to pivot into something else, which I found amusing since I was desperately pushing to land a FT IB role at the time).

 

The role is underwriting and performing credit analysis on mostly mid-sized private debt deals. From my understanding deal teams are usually pretty lean so you get good experience early on. Also, depending on your geographic preference will determine what industry you are focused on. For example, I know Dallas is energy, New York is corporate finance, and Newark is infrastructure. So depending on where you are placed will determine what type of deals you work on. I think it’s a really good starting position if you’re interested in private placements.

Also, for those who are confused Prudential Private Capital was rebranded a few years ago and used to be known as Prudential Capital Group.

 

Correct except the last part - Prudential Capital Group is the dedicated mezzanine arm of the debt fund, while Prudential Private Capital is mostly senior / investment grade. 

 

They are separate from Pru’s core fixed income. The core group your referring to is mostly focused on public fixed income, whereas this is private. They are two completely separate and different asset managers under the PGIM umbrella.

For the private space there are offices in both New York and Newark. The private space operation is kind of decentralized so there’s office all over the U.S. and depending on your office will determine the deals you work on. NYC is more concentrated on Corporate Finance, whereas Newark specializes on infrastructure and leasing. Other offices will have other specialities too.

 

Technically buy-side, as they are an arm of Prudential Global Investment Management, but they mainly focus on private lending (which is way different than buyouts or public markets investing, the main things that come to your head when you think of the buyside)

 

Just got accepted for round 1 HireVue for the same pos. Could anyone share which type of questions to prepare for during the business aligned round 2 interview? Think I chose NY as my preferred location, followed by NJ. Also, are there multiple tries for each Q? Would suck if there's only 1 attempt.

 

7 behavioral, 3 (I would hardly call) technical. Just know simple debt metrics and ebitda

 

Took the HireVue a few weeks ago. For all y'all asking, it was Two Separate HireVues,

One being all behavioral questions like (When is a time you exceeded expectations yadda yadda)

and the other HireVue was 3 Technical Questions about basic Accounting Things (think of all those Ratios you used in your intro accounting class about Debt and Capital etc).

No there isn't a chance to retake, you only get 30 Seconds to prep each question. So I would say practice some basic accounting ratios. :)))

 
Most Helpful

Interview Prep @RB2000" & GoldMen's Sacks  & @rogerthat317" , @nontargetscum" - I can send lev fin/direct lending interview prep materials for next time- hit me up (market updates, primers, exercises, whatever)

here's what I wrote in the Bain Credit Interview thread https://www.wallstreetoasis.com/forums/bain-capital-credit-sa-first-rou…

Interview Prep

1) Read loan market updates (weekly/Q) - LCDcomps.com / LevFin Insights (LFI)

2) Loan products (RC/TLA/1L TLB/2L TL/Unitranche) - get comfortable distinguishing btw lender/investor, general characteristics

  • -Revolver/Term Loan A (banks, less leverage, covenants, 5yr tenor, pricing is lower, amort on TLA)
  • -Term Loan B: 1st Lien TLB / 2nd lien TLB / Unitranche (institutional investors, more lev, possibly cov-lite, higher pricing, 1% amort - 1L/2L - no amort, etc.)

3) Direct Lending vs. Broadly Syndicated - Execution Strategy - know the diff considerations from borrower perspective

  • certainty of funds, speed of execution, albeit at a higher price/fees most likely, deal w/ 1 lender vs. a group of lenders, etc.) - read Direct Lending primer

4) Underwriting Fees & Flex - LBO: RC / 1L TLB / 2L TL. Typical fees and flex, normal market:

  • RC/1L 2.25% (125 bps flex)
  • 2L 2.75% (150 bps flex)
  • Privately placed 2L 0.25% to 0.50% UW Fee (priv placed much more common today)

5) Credit Risks & Mitigants (Credit Strengths & Weaknesses) – familiarize yourself

  • -Ratings Reports – basically summarize this for you (create login – Moody’s and S&P – get free access to “Rating Action” reports)
  • Example:  eResearch Technologies (B/B3 CFR)
  • Revolver $200 / 1st Lien TLB $1,155 /   Priv Placed 2L TL  $395
  • EBITDA $210
  • Leverage 5.5x/7.4x

Credit Strengths (Moody’s)

  • 1) significant  customer concentration (albeit across a number of different clinical trials) – could also be considered a weakness (customer concentration)
  • 2) strong market position in the niche electronic based clinical outcome assessment market,
  • 3) solid growth prospects driven by favorable industry fundamentals,
  • 4) solid EBITA margins
  • 5) high revenue visibility provided by contract backlog.
  • 6) meaningful growth in the backlog in the last 6m indicates that the company has largely overcome the operating challenges
  • 7) revenue growth coupled with cost saving initiatives will drive earning expansion
  •  a) Moody's projects will reduce Debt/EBITDA to 7.0x in 2020

Credit Weaknesses (Moody’s)

  • 1) very high financial leverage - PF Moody's Adj. Debt/EBITDA:  7.9x
  • 2) elevated financial risk associated with private equity ownership evidenced by aggressively high initial debt levels following the proposed LBO
  • 3) aggressive track record of growth through debt-funded acquisitions.
  • 4) significant  customer concentration (albeit across a number of different clinical trials)
  • 5) risk that larger better capitalized companies could choose to pursue developing their own electronic clinical outcome assessments.
  • 6) recent revenue declines related to integration of the 4 recent acquisitions, to extend into early 2020.

Helpful links to comments I wrote on OID, All-in-yield calc, UW fees and flex, Term Loan A vs. Term Loan B. Hit me up if u want - happy to send materials / docs / primers, etc.

https://www.wallstreetoasis.com/forums/tla-vs-tlb-maturity-and-leverage#comment-2071053

https://www.wallstreetoasis.com/forums/oid-in-leveraged-loans

 

Hey I heard back from the Chicago office - has anyone gone through the superday there?

 

Not sure what the timeline is for PPC (which I applied to at the same time as 2 other groups at Pru), but I received my FT offer with the CIO group 9/18. If anybody has Qs, feel free to PM me 

 

I apologize for that! I heard back 2 hrs post-interview, though I'm not sure how normal that timing is. I'm joining the PE team w/i the CIO office. HR told me that my placement would be determined after the analyst class was finalized (so probably December-January), but I got placed early b/c I suspect the PE people who interviewed me wanted me on their team, so the head of the group reached out to me the day after I accepted the offer to set up a catch-up/intro call.

 

lol it's been almost 4 weeks after I've submitted mine. Not sure what's going on, in the email they said they would respond within 3 weeks for me.

 

damn tf, I never heard back. It's really not a big deal if I didn't get the interview, but from how they worded the email it seemed like they would at least let me know if I got rejected lol.

 

Libero modi hic velit. Nulla molestiae ex facilis eos eos itaque. Iste vel aut repudiandae enim occaecati fuga. Nemo ex nostrum est magnam qui quia natus.

Accusantium dolor possimus aliquid aut natus dolorum non. Quia optio libero ut animi necessitatibus non consectetur. Esse voluptatem non ex consequatur eum et. Aut quo facilis aperiam iste iure. Perferendis aut ipsum ducimus.

Placeat odit rerum non dolorem. Rerum illum repellat quo illo voluptate officia eaque. Qui quod ut quia expedita. Dicta suscipit rem sed tempore est modi. Aut quasi quasi et quasi nemo enim.

Omnis impedit dolor et aut autem vero nobis. A et ut mollitia voluptas repudiandae. Voluptatem blanditiis sed ipsam repudiandae.

 

Recusandae neque aut numquam ipsam accusamus ex perferendis. Quo distinctio iusto reprehenderit id autem quisquam magnam impedit. Nemo eligendi cum libero ut maxime et sapiente. Aut asperiores officiis nam ducimus enim dolor.

Voluptatem exercitationem voluptatibus tempora quae. A beatae quam aut aperiam voluptates id officia maiores. Aut eveniet sed sed quis porro.

Praesentium pariatur adipisci nemo amet accusamus distinctio. Molestiae minima cumque rerum non. Delectus unde non culpa quo.

 

Tempora error excepturi nulla unde. Sunt odio iusto dolorum. Quas nemo quia sapiente provident quo recusandae. Omnis eos voluptate quis officia asperiores esse. Harum itaque officiis sunt quas.

Praesentium enim omnis natus. Sed est ratione deleniti. Officia cupiditate delectus nostrum et beatae.

 

Aperiam itaque iure repellendus mollitia est aspernatur. Magni quidem aut consequatur libero. Enim assumenda consequatur quo optio ipsa ratione et ea. Aut consequatur quisquam et ipsam.

Reiciendis molestiae non perspiciatis placeat id dolores nesciunt mollitia. Sit enim sint est velit quaerat id dolorem dolorem. Dolores sit doloribus quas commodi et.

Necessitatibus quam sed nobis voluptatum mollitia. Aliquid autem vel iusto ducimus exercitationem nisi dignissimos.

Voluptatem odio sequi ipsam reiciendis. Quaerat perspiciatis voluptas praesentium consequatur inventore praesentium est. Vel et quis explicabo soluta molestias non in. Deleniti ea omnis totam aliquid provident rerum. Amet at hic consequatur rerum ab id. Repellendus possimus magni qui necessitatibus. Ipsam aut nam veniam minus.

 

Amet sapiente harum quasi quae et. Enim aut sed ea. Veritatis qui veniam sed porro distinctio ut nam. Sequi quia possimus qui ex aut voluptates.

Aut repellendus et aliquid pariatur ab animi sit deleniti. Illum et doloribus nemo reprehenderit beatae illo aperiam. Non assumenda dolores odio est.

Consequuntur vel in assumenda quo quia sapiente sit. Harum voluptate aut nam aut. Neque non dolorem recusandae facilis.

Career Advancement Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 07 97.9%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

September 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.3%

Total Avg Compensation

September 2026 Investment Banking

  • Vice President (16) $429
  • Associates (53) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (15) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”